These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890 [TBL] [Abstract][Full Text] [Related]
5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481 [TBL] [Abstract][Full Text] [Related]
6. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis. Weinberg JM Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953 [TBL] [Abstract][Full Text] [Related]
7. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials. Brimhall AK; King LN; Licciardone JC; Jacobe H; Menter A Br J Dermatol; 2008 Aug; 159(2):274-85. PubMed ID: 18547300 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Reich K; Sinclair R; Roberts G; Griffiths CE; Tabberer M; Barker J Curr Med Res Opin; 2008 May; 24(5):1237-54. PubMed ID: 18355421 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of systemic therapies for moderate to severe psoriasis. Sizto S; Bansback N; Feldman SR; Willian MK; Anis AH Br J Dermatol; 2009 Jun; 160(6):1264-72. PubMed ID: 19120346 [TBL] [Abstract][Full Text] [Related]
11. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070 [TBL] [Abstract][Full Text] [Related]
12. Infliximab for the treatment of adults with psoriasis. Loveman E; Turner D; Hartwell D; Cooper K; Clegg A Health Technol Assess; 2009 Jun; 13 Suppl 1():55-60. PubMed ID: 19567215 [TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of biologic therapies for plaque psoriasis. Ahn CS; Gustafson CJ; Sandoval LF; Davis SA; Feldman SR Am J Clin Dermatol; 2013 Aug; 14(4):315-26. PubMed ID: 23696234 [TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
15. Ustekinumab for the treatment of moderate to severe psoriasis. Gospodarevskaya E; Picot J; Cooper K; Loveman E; Takeda A Health Technol Assess; 2009 Oct; 13 Suppl 3():61-6. PubMed ID: 19846031 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials]. Zhang Z; Schmitt J; Wozel G; Kirch W Med Klin (Munich); 2009 Feb; 104(2):125-36. PubMed ID: 19242664 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis. Menter A; Gordon K; Carey W; Hamilton T; Glazer S; Caro I; Li N; Gulliver W Arch Dermatol; 2005 Jan; 141(1):31-8. PubMed ID: 15655139 [TBL] [Abstract][Full Text] [Related]
18. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [TBL] [Abstract][Full Text] [Related]
19. Adalimumab for the treatment of psoriasis. Turner D; Picot J; Cooper K; Loveman E Health Technol Assess; 2009 Sep; 13 Suppl 2():49-54. PubMed ID: 19804689 [TBL] [Abstract][Full Text] [Related]
20. Antistreptococcal interventions for guttate and chronic plaque psoriasis. Dupire G; Droitcourt C; Hughes C; Le Cleach L Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011571. PubMed ID: 30835819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]